# Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT

> **NCT00647205** · PHASE4 · COMPLETED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 240 (estimated)

## Conditions studied

- HIV Infections
- Tuberculosis

## Interventions

- **DEVICE:** QuantiFERON TB Gold In-Tube
- **DEVICE:** T-SPOT.TB®

## Key facts

- **NCT ID:** NCT00647205
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2010-05
- **Final completion:** 2010-11
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2011-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00647205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00647205, "Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00647205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*